Medical therapy for chronic refractory angina

Gregory W. Barsness, Thomas J. Kiernan, David Holmes

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Medical therapy is the cornerstone of treatment for patients with chronic refractory angina, as it is across the entire spectrum of vascular disease. As part of a comprehensive risk modification program, including exercise, diet, and appropriate revascularization, optimal medical therapy offers significant benefit in reducing symptoms of ischemic heart disease and improving long-term prognosis. Indeed, current medical regimens, far superior to those offered only a decade ago, afford patients with refractory angina a marked survival benefit. Newer agents have demonstrated a marked symptomatic benefit, as well. This chapter will explore the importance of optimal medical therapy in improving prognosis, as well as details potential for imparting a much needed boost to quality of life and symptom amelioration.

Original languageEnglish (US)
Title of host publicationCoronary Artery Disease
Subtitle of host publicationNew Approaches without Traditional Revascularization
PublisherSpringer-Verlag London Ltd
Pages39-51
Number of pages13
Volume9781846287121
ISBN (Electronic)9781846287121
ISBN (Print)1846284600, 9781846284601
DOIs
StatePublished - Apr 1 2012

Fingerprint

Therapeutics
Vascular Diseases
Myocardial Ischemia
Quality of Life
Exercise
Diet
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Barsness, G. W., Kiernan, T. J., & Holmes, D. (2012). Medical therapy for chronic refractory angina. In Coronary Artery Disease: New Approaches without Traditional Revascularization (Vol. 9781846287121, pp. 39-51). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-84628-712-1_5

Medical therapy for chronic refractory angina. / Barsness, Gregory W.; Kiernan, Thomas J.; Holmes, David.

Coronary Artery Disease: New Approaches without Traditional Revascularization. Vol. 9781846287121 Springer-Verlag London Ltd, 2012. p. 39-51.

Research output: Chapter in Book/Report/Conference proceedingChapter

Barsness, GW, Kiernan, TJ & Holmes, D 2012, Medical therapy for chronic refractory angina. in Coronary Artery Disease: New Approaches without Traditional Revascularization. vol. 9781846287121, Springer-Verlag London Ltd, pp. 39-51. https://doi.org/10.1007/978-1-84628-712-1_5
Barsness GW, Kiernan TJ, Holmes D. Medical therapy for chronic refractory angina. In Coronary Artery Disease: New Approaches without Traditional Revascularization. Vol. 9781846287121. Springer-Verlag London Ltd. 2012. p. 39-51 https://doi.org/10.1007/978-1-84628-712-1_5
Barsness, Gregory W. ; Kiernan, Thomas J. ; Holmes, David. / Medical therapy for chronic refractory angina. Coronary Artery Disease: New Approaches without Traditional Revascularization. Vol. 9781846287121 Springer-Verlag London Ltd, 2012. pp. 39-51
@inbook{71852212d15a468a99305d9659455bb0,
title = "Medical therapy for chronic refractory angina",
abstract = "Medical therapy is the cornerstone of treatment for patients with chronic refractory angina, as it is across the entire spectrum of vascular disease. As part of a comprehensive risk modification program, including exercise, diet, and appropriate revascularization, optimal medical therapy offers significant benefit in reducing symptoms of ischemic heart disease and improving long-term prognosis. Indeed, current medical regimens, far superior to those offered only a decade ago, afford patients with refractory angina a marked survival benefit. Newer agents have demonstrated a marked symptomatic benefit, as well. This chapter will explore the importance of optimal medical therapy in improving prognosis, as well as details potential for imparting a much needed boost to quality of life and symptom amelioration.",
author = "Barsness, {Gregory W.} and Kiernan, {Thomas J.} and David Holmes",
year = "2012",
month = "4",
day = "1",
doi = "10.1007/978-1-84628-712-1_5",
language = "English (US)",
isbn = "1846284600",
volume = "9781846287121",
pages = "39--51",
booktitle = "Coronary Artery Disease",
publisher = "Springer-Verlag London Ltd",

}

TY - CHAP

T1 - Medical therapy for chronic refractory angina

AU - Barsness, Gregory W.

AU - Kiernan, Thomas J.

AU - Holmes, David

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Medical therapy is the cornerstone of treatment for patients with chronic refractory angina, as it is across the entire spectrum of vascular disease. As part of a comprehensive risk modification program, including exercise, diet, and appropriate revascularization, optimal medical therapy offers significant benefit in reducing symptoms of ischemic heart disease and improving long-term prognosis. Indeed, current medical regimens, far superior to those offered only a decade ago, afford patients with refractory angina a marked survival benefit. Newer agents have demonstrated a marked symptomatic benefit, as well. This chapter will explore the importance of optimal medical therapy in improving prognosis, as well as details potential for imparting a much needed boost to quality of life and symptom amelioration.

AB - Medical therapy is the cornerstone of treatment for patients with chronic refractory angina, as it is across the entire spectrum of vascular disease. As part of a comprehensive risk modification program, including exercise, diet, and appropriate revascularization, optimal medical therapy offers significant benefit in reducing symptoms of ischemic heart disease and improving long-term prognosis. Indeed, current medical regimens, far superior to those offered only a decade ago, afford patients with refractory angina a marked survival benefit. Newer agents have demonstrated a marked symptomatic benefit, as well. This chapter will explore the importance of optimal medical therapy in improving prognosis, as well as details potential for imparting a much needed boost to quality of life and symptom amelioration.

UR - http://www.scopus.com/inward/record.url?scp=84930015854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930015854&partnerID=8YFLogxK

U2 - 10.1007/978-1-84628-712-1_5

DO - 10.1007/978-1-84628-712-1_5

M3 - Chapter

AN - SCOPUS:84930015854

SN - 1846284600

SN - 9781846284601

VL - 9781846287121

SP - 39

EP - 51

BT - Coronary Artery Disease

PB - Springer-Verlag London Ltd

ER -